Sanofi (NYSE: SNY) announced that the license and development agreement between Sanofi and kaléo, formerly Intelliject Inc., the developer of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE